Ayala Pharmaceuticals Announces the Appointment of Vered Bisker-Leib, Ph.D. To Its Board of Directors
August 20, 2020 08:01 ET
|
Ayala Pharmaceuticals
REHOVOT, Israel and WILMINGTON, Del., Aug. 20, 2020 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (Nasdaq: AYLA) (the Company or Ayala), a clinical-stage oncology company focused on...
Ayala Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Business Update
August 13, 2020 08:01 ET
|
Ayala Pharmaceuticals
– New interim data from Phase 2 ACCURACY study of AL101 for the treatment of R/M ACC to be presented at ESMO 2020 – – On track to initiate patient dosing in Phase 2 TENACITY study of...
Ayala Pharmaceuticals to Present Updated Data from Ongoing Phase 2 ACCURACY Trial of AL101 for the Treatment of R/M Adenoid Cystic Carcinoma at the European Society for Medical Oncology (ESMO) Virtual Congress 2020
July 27, 2020 08:01 ET
|
Ayala Pharmaceuticals
REHOVOT, Israel and WILMINGTON, Del., July 27, 2020 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA), a clinical-stage oncology company focused on developing and commercializing...
Ayala Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Business Update
June 22, 2020 08:00 ET
|
Ayala Pharmaceuticals
– Completed upsized initial public offering raising a total of $59.1 million in gross proceeds – Current cash balance expected to fund operations into second half of 2022 – Fast Track...
Ayala Pharmaceuticals to Present at Upcoming Investor Conferences
June 01, 2020 08:01 ET
|
Ayala Pharmaceuticals
REHOVOT, Israel and WILMINGTON, Del., June 01, 2020 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA), a clinical-stage oncology company focused on developing and commercializing small...
Ayala Pharmaceuticals Announces Closing of Initial Public Offering
May 12, 2020 16:01 ET
|
Ayala Pharmaceuticals
REHOVOT, Israel & WILMINGTON, Del., May 12, 2020 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA), a clinical-stage oncology company focused on developing and commercializing small...
Ayala Pharmaceuticals Announces Pricing of Initial Public Offering
May 07, 2020 18:57 ET
|
Ayala Pharmaceuticals
REHOVOT, Israel and WILMINGTON, Del., May 07, 2020 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA), a clinical-stage oncology company focused on developing and commercializing small...